About
Samantha Guinn, PhD, is an Analyst at the Novartis Venture Fund. She was previously an Associate at Flagship Pioneering, where she worked on venture hypotheses, therapeutic concepts, and landscaping assessments, and earlier conducted research in the lab of Dr. Elizabeth Jaffee focused on cancer-associated fibroblast cellular crosstalk in pancreatic cancer. She holds a BSc from Colorado State University, an MMSc in Immunology from Harvard Medical School, and a PhD in Immunology from Johns Hopkins University School of Medicine.
Experience
- Novartis Venture FundAnalystcurrent2025 — present
- Flagship PioneeringAssociate2024 — 2025Boston, Massachusetts, United States
- Flagship PioneeringFellow2024Boston, Massachusetts, United States
- NucleateDirector of Partnership2022 — 2024Baltimore Chapter
- CSSi LifeSciencesCommercialization and Business Development Fellow2021 — 2024Baltimore, Maryland, United States
- Doctor of Philosophy - PhD, ImmunologyThe Johns Hopkins University School of Medicine2020 — 2024
- Harvard Medical SchoolResearch2016 — 2020
- Colorado State UniversityStudent Body President2014 — 2015Fort Collins, CO
- Associated Students of Colorado State UniversityDeputy Chief of Staff2013 — 2014Fort Collins, Colorado Area
Skills & more
Customer Relationship Management (CRM)1Trial ManagementImmunologyData PresentationTeaching1Peer-to-peerOncologyClinical Research1Medical Affairs1Peer Relationships1Regulatory GuidelinesMedical Background1
+11 more
Medical ScienceClinical DataCustomer ServiceResearchTime ManagementRelationship BuildingMentoringCommunicationLeadershipMicrosoft PowerPointMicrosoft OfficeFrom Samantha's professional profile.
Colleagues at Novartis Venture Fund
Adam Cotton
Principal at Novartis Venture Fund
Anís
Head of Scoping, Pharma at Deep Science Ventures
Anja Koenig
Global Head of NVF at Novartis Venture Fund
Anja König
Global Head at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Christoph Meier
Investor at Novartis Venture Fund
Elaine Jones
Investor at Novartis Venture Fund
Frequently asked questions
- Who is Samantha Guinn?
- Samantha Guinn, PhD, is an Analyst at the Novartis Venture Fund. She was previously an Associate at Flagship Pioneering, where she worked on venture hypotheses, therapeutic concepts, and landscaping assessments, and earlier conducted research in the lab of Dr. Elizabeth Jaffee focused on cancer-associated fibroblast cellular crosstalk in pancreatic cancer. She holds a BSc from Colorado State University, an MMSc in Immunology from Harvard Medical School, and a PhD in Immunology from Johns Hopkins University School of Medicine.
- Where does Samantha Guinn work?
- Samantha Guinn is Analyst at Novartis Venture Fund.
- Where did Samantha Guinn go to school?
- Samantha Guinn studied at The Johns Hopkins University School of Medicine (Doctor of Philosophy - PhD, Immunology); Harvard Medical School (Masters of Medical Science, Immunology); Colorado State University (Bachelor of Science - BS, Microbiology).
Same school
Also attended The Johns Hopkins University School of Medicine28
Hal PazInvestor at Khosla VenturesRochelle WalenskyExecutive Partner at Flare Capital PartnersBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersS.K. LeeExecutive Coach at Roble VenturesKayarash KarimianSenior Associate at Cure VenturesGreg HornerInvestor at Sand Hill Angels
.png)
+ 22 more
Also attended Harvard Medical School143
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 137 more
Also attended Colorado State University36
Paul OsmundsonVice President Strategy & Innovation - ARUP Laboratories at EPIC VENTURESTim WeelborgGeneral Partner and co-founder of Homegrown CapitalRon KammerzellInvestor at Golden EagleAlbert J. RobichaudPartner at Cure VenturesLarry BurgessExecutives in Residence at GENERAL INCEPTIONAmy FullerExecutive Assistant at SQUADRA VENTURES
+ 30 more
Shared employers
Also worked at Flagship Pioneering76
Anika GuptaInvestor at GV (Google Ventures)Noubar AfeyanInvestor at Flagship PioneeringSamir KaulInvestor at Khosla VenturesCassidy BlundellPartner at Mission BiocapitalDavid KoleskyPrincipal at MPM BioImpactDiana BernsteinDirector at Northpond Ventures
+ 70 more
Also worked at Nucleate33
Madison LenormandInvestor at DaphniJun JeonInvestor at Khosla VenturesEmily LindbergAssociate & Head of Research at Undeterred CapitalKylie TrettnerInvestment & Research Analyst at Undeterred CapitalStella PaffenholzSenior Associate at Atlas VentureTed Ling HuFellow, Human Augmentation at Prime Movers Lab
+ 27 more
Also worked at Harvard Medical School169
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesJulie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux Capital
+ 163 more
Also worked at Colorado State University9
Peter AdamsFounder and Managing Partner at Rockies Venture Adviser, LlcDuncan CarlsonPrincipal at LowercarbonAaron G.L. FletcherManaging Partner and Co-Founder at Bios PartnersKate DanaherManaging Director at S2G InvestmentsRemy C. AltmanAssociate at Gunderson DettmerMorgan DeFoortPartner at Factor[e] Ventures
+ 3 more